Oppenheimer Starts Carlisle (CSL) at Outperform

Oppenheimer initiated coverage on Carlisle (NYSE: CSL) with an Outperform rating and a price target of $105.00.

For an analyst ratings summary and ratings history on Carlisle click here. For more ratings news on Carlisle click here.

Shares of Carlisle closed at $90.38 yesterday.

You May Also Be Interested In

• CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
• Craig-Hallum Assumes Guardant Health (GH) at Buy, 'We think that GH is undervalued'
• Intermediate Capital Group (ICP:LN) (ICGUF) PT Raised to GBP22.50 at Citi